Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012). (Q46928445)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 February 2014

Language	Label	Description	Also known as
English	Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).	scientific article published on 20 February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012). (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

Gram-negative bacteria

0 references

urinary tract infection

1 reference

based on heuristic

inferred from title

3

object named as

Helio S Sader

1 reference

Europe PubMed Central

26 December 2017

1

object named as

Robert K Flamm

1 reference

Europe PubMed Central

26 December 2017

4

object named as

Ronald N Jones

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

author name string

David J Farrell

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

language of work or name

0 references

publication date

20 February 2014

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

69

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

1589-1598

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized stud

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

The perpetual challenge of infectious diseases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Nosocomial bloodstream infections: organisms, risk factors, and implications

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

A Comprehensive review of abdominal infections.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Combating antimicrobial resistance: policy recommendations to save lives

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU025

21 January 2018

Identifiers

10.1093/JAC/DKU025

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/24562613

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46928445&oldid=1940470267"